Skip to main content
Erschienen in: Current Fungal Infection Reports 3/2016

30.05.2016 | Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Sporotrichosis in Children: an Update

verfasst von: Andrés Tirado-Sánchez, Alexandro Bonifaz

Erschienen in: Current Fungal Infection Reports | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Sporotrichosis, a disease caused by the saprophytic, dimorphic fungus Sporothrix schenckii, is currently diagnosed worldwide, especially in some tropical and subtropical areas. The infection usually occurs after traumatic inoculation of soil, plants, and organic matter containing the fungus. Certain activities, such as floriculture, agriculture, mining, and wood exploitation, and zoonotic transmission are associated with the mycosis. In humans, the disease is limited to skin, subcutaneous tissue, and the proximal lymphatic. It occurs commonly as lymphocutaneous or fixed lesions predominantly affect the upper limbs and face, the latter location is frequent in children. However, sporotrichosis in children is uncommonly seen. Data about the disease on this specific group of patients is scanty. The gold standard for diagnosis is culture. Nevertheless, there are other recently added methods (serological, histopathological, and molecular) useful for an accurate diagnosis. Itraconazole is the first choice of treatment for sporotrichosis; however, potassium iodide is also an effective option, mainly in children.
Literatur
1.•
Zurück zum Zitat Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract. 2014;2014, 272376. This review paper gives an overview of the disease.PubMedPubMedCentral Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract. 2014;2014, 272376. This review paper gives an overview of the disease.PubMedPubMedCentral
2.
Zurück zum Zitat McGuinness SL, Boyd R, Kidd S, McLeod C, Krause VL, Ralph AP. Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory. Australia BMC Infect Dis. 2016;16(1):16.PubMedCrossRef McGuinness SL, Boyd R, Kidd S, McLeod C, Krause VL, Ralph AP. Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory. Australia BMC Infect Dis. 2016;16(1):16.PubMedCrossRef
3.••
Zurück zum Zitat Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53(1):3–14. This paper shows a clear distribution of the disease worldwide.PubMedCrossRef Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53(1):3–14. This paper shows a clear distribution of the disease worldwide.PubMedCrossRef
4.
Zurück zum Zitat Marimon R, Gené J, Cano J, Trilles L, Dos Santos LM, Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol. 2006;44(9):3251–6.PubMedPubMedCentralCrossRef Marimon R, Gené J, Cano J, Trilles L, Dos Santos LM, Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol. 2006;44(9):3251–6.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Sanchotene KO, Madrid IM, Klafke GB, Bergamashi M, Della Terra PP, Rodrigues AM, et al. Sporothrix brasiliensis outbreaks and the rapid emergence of feline sporotrichosis. Mycoses. 2015;58(11):652–8.PubMedCrossRef Sanchotene KO, Madrid IM, Klafke GB, Bergamashi M, Della Terra PP, Rodrigues AM, et al. Sporothrix brasiliensis outbreaks and the rapid emergence of feline sporotrichosis. Mycoses. 2015;58(11):652–8.PubMedCrossRef
6.
Zurück zum Zitat Gremião ID, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA. Feline sporotrichosis: epidemiological and clinical aspects. Med Mycol. 2015;53(1):15–21.PubMedCrossRef Gremião ID, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA. Feline sporotrichosis: epidemiological and clinical aspects. Med Mycol. 2015;53(1):15–21.PubMedCrossRef
7.
Zurück zum Zitat Barros MB, Costa DL, Schubach TM, do Valle AC, Lorenzi NP, Teixeira JL, et al. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J. 2008;27(3):246–50.PubMedCrossRef Barros MB, Costa DL, Schubach TM, do Valle AC, Lorenzi NP, Teixeira JL, et al. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J. 2008;27(3):246–50.PubMedCrossRef
8.
Zurück zum Zitat Govender NP, Maphanga TG, Zulu TG, Patel J, Walaza S, Jacobs C, et al. An outbreak of lymphocutaneous sporotrichosis among mine-workers in South Africa. PLoS Negl Trop Dis. 2015;9(9), e0004096.PubMedPubMedCentralCrossRef Govender NP, Maphanga TG, Zulu TG, Patel J, Walaza S, Jacobs C, et al. An outbreak of lymphocutaneous sporotrichosis among mine-workers in South Africa. PLoS Negl Trop Dis. 2015;9(9), e0004096.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Alves SH, Boettcher CS, Oliveira DC, Tronco-Alves GR, Sgaria MA, Thadeu P, et al. Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles. Rev Soc Bras Med Trop. 2010;43(5):523–5.PubMedCrossRef Alves SH, Boettcher CS, Oliveira DC, Tronco-Alves GR, Sgaria MA, Thadeu P, et al. Sporothrix schenckii associated with armadillo hunting in Southern Brazil: epidemiological and antifungal susceptibility profiles. Rev Soc Bras Med Trop. 2010;43(5):523–5.PubMedCrossRef
10.••
Zurück zum Zitat Ramírez Soto MC. Sporotrichosis: the story of an endemic region in Peru over 28 Years (1985 to 2012). PLoS One 2015; 10(6):e0127924. This paper shows clearly the risk factors for sporotrichosis in an endemic region. Ramírez Soto MC. Sporotrichosis: the story of an endemic region in Peru over 28 Years (1985 to 2012). PLoS One 2015; 10(6):e0127924. This paper shows clearly the risk factors for sporotrichosis in an endemic region.
11.
Zurück zum Zitat Song Y, Li SS, Zhong SX, Liu YY, Yao L, Huo SS. Report of 457 sporotrichosis cases from Jilin province, northeast China, a serious endemic region. J Eur Acad Dermatol Venereol. 2013;27(3):313–8.PubMedCrossRef Song Y, Li SS, Zhong SX, Liu YY, Yao L, Huo SS. Report of 457 sporotrichosis cases from Jilin province, northeast China, a serious endemic region. J Eur Acad Dermatol Venereol. 2013;27(3):313–8.PubMedCrossRef
12.
Zurück zum Zitat Ursini F, Russo E, Leporini C, Calabria M, Bruno C, Tripolino C, et al. Lymphocutaneous Sporotrichosis during treatment with Anti-TNF-Alpha Monotherapy. Case Rep Rheumatol. 2015;2015:614504.PubMedPubMedCentral Ursini F, Russo E, Leporini C, Calabria M, Bruno C, Tripolino C, et al. Lymphocutaneous Sporotrichosis during treatment with Anti-TNF-Alpha Monotherapy. Case Rep Rheumatol. 2015;2015:614504.PubMedPubMedCentral
13.
Zurück zum Zitat Teixeira Mde M, Rodrigues AM, Tsui CK, de Almeida LG, Van Diepeningen AD, van den Ende BG, et al. Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Eukaryotic Cell. 2015;14(2):158–69.PubMedCrossRef Teixeira Mde M, Rodrigues AM, Tsui CK, de Almeida LG, Van Diepeningen AD, van den Ende BG, et al. Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Eukaryotic Cell. 2015;14(2):158–69.PubMedCrossRef
14.••
Zurück zum Zitat Rodrigues AM, de Hoog GS, de Camargo ZP. Molecular diagnosis of pathogenic sporothrix species. PLoS Negl Trop Dis. 2015;9(12), e0004190. This paper describes the virulence factors for disease development.PubMedPubMedCentralCrossRef Rodrigues AM, de Hoog GS, de Camargo ZP. Molecular diagnosis of pathogenic sporothrix species. PLoS Negl Trop Dis. 2015;9(12), e0004190. This paper describes the virulence factors for disease development.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Rodrigues AM, de Hoog GS, de Cássia PD, Brihante RS, Sidrim JJ, Gadelha MF, et al. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis. 2014;14:219.PubMedPubMedCentralCrossRef Rodrigues AM, de Hoog GS, de Cássia PD, Brihante RS, Sidrim JJ, Gadelha MF, et al. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis. 2014;14:219.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Rodrigues AM, de Hoog S, de Camargo ZP. Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol. 2013;51(4):405–12.PubMedCrossRef Rodrigues AM, de Hoog S, de Camargo ZP. Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol. 2013;51(4):405–12.PubMedCrossRef
17.
Zurück zum Zitat Schechtman RC. Sporotrichosis: Part I. Skinmed. 2010;8(4):216–20.PubMed Schechtman RC. Sporotrichosis: Part I. Skinmed. 2010;8(4):216–20.PubMed
18.••
Zurück zum Zitat Almeida-Paes R, de Oliveira LC, Oliveira MM, Gutierrez-Galhardo MC, Nosanchuk JD, Zancopé-Oliveira RM. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int. 2015;2015:212308. This paper describes the virulence factors for disease development.PubMedPubMedCentralCrossRef Almeida-Paes R, de Oliveira LC, Oliveira MM, Gutierrez-Galhardo MC, Nosanchuk JD, Zancopé-Oliveira RM. Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int. 2015;2015:212308. This paper describes the virulence factors for disease development.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Freitas DF, Santos SS, Almeida-Paes R, de Oliveira MM, do Valle AC, Gutierrez-Galhardo MC, et al. Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence. 2015;6(2):112–20.PubMedPubMedCentralCrossRef Freitas DF, Santos SS, Almeida-Paes R, de Oliveira MM, do Valle AC, Gutierrez-Galhardo MC, et al. Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence. 2015;6(2):112–20.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Mario DA, Santos RC, Denardi LB, Vaucher Rde A, Santurio JM, Alves SH. Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B. Rev Iberoam Micol. 2016;33(1):21–5.PubMedCrossRef Mario DA, Santos RC, Denardi LB, Vaucher Rde A, Santurio JM, Alves SH. Interference of melanin in the susceptibility profile of Sporothrix species to amphotericin B. Rev Iberoam Micol. 2016;33(1):21–5.PubMedCrossRef
21.
Zurück zum Zitat de Albornoz MB, Mendoza M, de Torres ED. Growth temperatures of isolates of Sporothrix schenckii from disseminated and fixed cutaneous lesions of sporotrichosis. Mycopathologia. 1986;95(2):81–3.PubMedCrossRef de Albornoz MB, Mendoza M, de Torres ED. Growth temperatures of isolates of Sporothrix schenckii from disseminated and fixed cutaneous lesions of sporotrichosis. Mycopathologia. 1986;95(2):81–3.PubMedCrossRef
22.
Zurück zum Zitat Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis. 1979;139(4):424–31.PubMedCrossRef Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis. 1979;139(4):424–31.PubMedCrossRef
23.
Zurück zum Zitat Fernandes KS, Mathews HL, Lopes Bezerra LM. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J Med Microbiol. 1999;48(2):195–203.PubMedCrossRef Fernandes KS, Mathews HL, Lopes Bezerra LM. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J Med Microbiol. 1999;48(2):195–203.PubMedCrossRef
25.
Zurück zum Zitat Nascimento RC, Espíndola NM, Castro RA, Teixeira PA, Loureiro y Penha CV, Lopes-Bezerra LM, et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol. 2008;38(11):3080–9.PubMedCrossRef Nascimento RC, Espíndola NM, Castro RA, Teixeira PA, Loureiro y Penha CV, Lopes-Bezerra LM, et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol. 2008;38(11):3080–9.PubMedCrossRef
26.
Zurück zum Zitat Moreira JA, Freitas DF, Lamas CC. The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection. 2015;43(3):267–76.PubMedCrossRef Moreira JA, Freitas DF, Lamas CC. The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection. 2015;43(3):267–76.PubMedCrossRef
27.
Zurück zum Zitat Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol. 1999;37(6):397–404.PubMedCrossRef Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol. 1999;37(6):397–404.PubMedCrossRef
29.
Zurück zum Zitat Takenaka M, Yoshizaki A, Utani A, Nishimoto K. A survey of 165 sporotrichosis cases examined in Nagasaki prefecture from 1951 to 2012. Mycoses. 2014;57(5):294–8.PubMedCrossRef Takenaka M, Yoshizaki A, Utani A, Nishimoto K. A survey of 165 sporotrichosis cases examined in Nagasaki prefecture from 1951 to 2012. Mycoses. 2014;57(5):294–8.PubMedCrossRef
30.
Zurück zum Zitat da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52(3 Pt 1):451–9.PubMedCrossRef da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52(3 Pt 1):451–9.PubMedCrossRef
31.
Zurück zum Zitat Freitas DF, Lima IA, Curi CL, Jordão L, Zancopé-Oliveira RM, Valle AC, et al. Acute dacryocystitis: another clinical manifestation of sporotrichosis. Mem Inst Oswaldo Cruz. 2014;109(2):262–4.PubMedCrossRef Freitas DF, Lima IA, Curi CL, Jordão L, Zancopé-Oliveira RM, Valle AC, et al. Acute dacryocystitis: another clinical manifestation of sporotrichosis. Mem Inst Oswaldo Cruz. 2014;109(2):262–4.PubMedCrossRef
32.
Zurück zum Zitat Ramírez Soto MC. Sporotrichosis in the ocular adnexa: 21 cases in an endemic area in Peru and review of the literature. Am J Ophthalmol. 2016;162:173–9. e3.PubMedCrossRef Ramírez Soto MC. Sporotrichosis in the ocular adnexa: 21 cases in an endemic area in Peru and review of the literature. Am J Ophthalmol. 2016;162:173–9. e3.PubMedCrossRef
33.
34.
Zurück zum Zitat Costa RO, Bernardes-Engemann AR, Azulay-Abulafia L, Benvenuto F, Neves Mde L, Lopes-Bezerra LM. Sporotrichosis in pregnancy: case reports of 5 patients in a zoonotic epidemic in Rio de Janeiro. Brazil An Bras Derm. 2011;86(5):995–8.CrossRef Costa RO, Bernardes-Engemann AR, Azulay-Abulafia L, Benvenuto F, Neves Mde L, Lopes-Bezerra LM. Sporotrichosis in pregnancy: case reports of 5 patients in a zoonotic epidemic in Rio de Janeiro. Brazil An Bras Derm. 2011;86(5):995–8.CrossRef
35.••
Zurück zum Zitat Bonifaz A, Saúl A, Paredes-Solis V, Fierro L, Rosales A, Palacios C, et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol. 2007;24(4):369–72. This paper shows clearly the clinical spectrum for sporotrichosis in children.PubMedCrossRef Bonifaz A, Saúl A, Paredes-Solis V, Fierro L, Rosales A, Palacios C, et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol. 2007;24(4):369–72. This paper shows clearly the clinical spectrum for sporotrichosis in children.PubMedCrossRef
36.
Zurück zum Zitat Hernández PR, Borregales TE, de Garcia MM, Sauerteig E, Salfelder K. Symmetrical deforming cutaneous sporotrichosis of long duration. Mycoses. 1992;35(1–2):43–5. Hernández PR, Borregales TE, de Garcia MM, Sauerteig E, Salfelder K. Symmetrical deforming cutaneous sporotrichosis of long duration. Mycoses. 1992;35(1–2):43–5.
38.
Zurück zum Zitat López-Romero E, Reyes-Montes Mdel R, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011;6(1):85–102.PubMedCrossRef López-Romero E, Reyes-Montes Mdel R, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011;6(1):85–102.PubMedCrossRef
39.
Zurück zum Zitat Schechtman RC. Sporotrichosis: Part II. Skinmed. 2010;8(5):275–80.PubMed Schechtman RC. Sporotrichosis: Part II. Skinmed. 2010;8(5):275–80.PubMed
40.
Zurück zum Zitat Bonifaz A, Rojas-Padilla R, Tirado-Sánchez A. Sporotrichosis. The state of the art. In Medical Mycology: Current Trends and Future Prospects. Mehdi Razzaghi-Abyaneh, Masoomeh Shams-Ghahfarokhi, Mahendra Rai Eds. CRC Press, 2015. Pp. 234–53. Bonifaz A, Rojas-Padilla R, Tirado-Sánchez A. Sporotrichosis. The state of the art. In Medical Mycology: Current Trends and Future Prospects. Mehdi Razzaghi-Abyaneh, Masoomeh Shams-Ghahfarokhi, Mahendra Rai Eds. CRC Press, 2015. Pp. 234–53.
41.
Zurück zum Zitat Quintella LP, Passos SR, do Vale AC, Galhardo MC, Barros MB, Cuzzi T, et al. Histopathology of cutaneous sporotrichosis in Rio de Janeiro: a series of 119 consecutive cases. J Cutan Pathol. 2011;38(1):25–32.PubMedCrossRef Quintella LP, Passos SR, do Vale AC, Galhardo MC, Barros MB, Cuzzi T, et al. Histopathology of cutaneous sporotrichosis in Rio de Janeiro: a series of 119 consecutive cases. J Cutan Pathol. 2011;38(1):25–32.PubMedCrossRef
42.
Zurück zum Zitat Liu X, Zhang Z, Hou B, Wang D, Sun T, Li F, et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol. 2013;27(12):1491–7.PubMedCrossRef Liu X, Zhang Z, Hou B, Wang D, Sun T, Li F, et al. Rapid identification of Sporothrix schenckii in biopsy tissue by PCR. J Eur Acad Dermatol Venereol. 2013;27(12):1491–7.PubMedCrossRef
43.
44.
Zurück zum Zitat Mata-Essayag S, Delgado A, Colella MT, Landaeta-Nezer ME, Rosello A, Perez de Salazar C, et al. Epidemiology of sporotrichosis in Venezuela. Int J Dermatol. 2013;52(8):974–80.PubMedCrossRef Mata-Essayag S, Delgado A, Colella MT, Landaeta-Nezer ME, Rosello A, Perez de Salazar C, et al. Epidemiology of sporotrichosis in Venezuela. Int J Dermatol. 2013;52(8):974–80.PubMedCrossRef
45.
Zurück zum Zitat Song Y, Yao L, Zhong SX, Tian YP, Liu YY, Li SS. Infant sporotrichosis in northeast China: a report of 15 cases. Int J Dermatol. 2011;50(5):522–9.PubMedCrossRef Song Y, Yao L, Zhong SX, Tian YP, Liu YY, Li SS. Infant sporotrichosis in northeast China: a report of 15 cases. Int J Dermatol. 2011;50(5):522–9.PubMedCrossRef
46.
Zurück zum Zitat Falqueto A, Bravim Maifrede S, Araujo RM. Unusual clinical presentation of sporotrichosis in three members of one family. Int J Dermatol. 2012;51(4):434–8.PubMedCrossRef Falqueto A, Bravim Maifrede S, Araujo RM. Unusual clinical presentation of sporotrichosis in three members of one family. Int J Dermatol. 2012;51(4):434–8.PubMedCrossRef
47.
Zurück zum Zitat Lee H, Kim do Y, Lee KH, Choi JS, Suh MK. Deformity of the earlobe caused by fixed cutaneous sporotrichosis in a pediatric patient. Int J Dermatol. 2015;54(5):e187–9.PubMedCrossRef Lee H, Kim do Y, Lee KH, Choi JS, Suh MK. Deformity of the earlobe caused by fixed cutaneous sporotrichosis in a pediatric patient. Int J Dermatol. 2015;54(5):e187–9.PubMedCrossRef
48.
Zurück zum Zitat Mahajan VK, Sharma NL, Sharma RC, Gupta ML, Garg G, Kanga AK. Cutaneous sporotrichosis in Himachal Pradesh. India Mycoses. 2005;48(1):25–31.PubMedCrossRef Mahajan VK, Sharma NL, Sharma RC, Gupta ML, Garg G, Kanga AK. Cutaneous sporotrichosis in Himachal Pradesh. India Mycoses. 2005;48(1):25–31.PubMedCrossRef
49.
Zurück zum Zitat Tang MM, Tang JJ, Gill P, Chang CC, Baba R. Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia. Int J Dermatol. 2012;51(6):702–8.PubMedCrossRef Tang MM, Tang JJ, Gill P, Chang CC, Baba R. Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia. Int J Dermatol. 2012;51(6):702–8.PubMedCrossRef
50.
Zurück zum Zitat Tlougan BE, Podjasek JO, Patel SP, Nguyen XH, Hansen RC. Neonatal sporotrichosis. Pediatr Dermatol. 2009;26(5):563–5.PubMedCrossRef Tlougan BE, Podjasek JO, Patel SP, Nguyen XH, Hansen RC. Neonatal sporotrichosis. Pediatr Dermatol. 2009;26(5):563–5.PubMedCrossRef
51.
Zurück zum Zitat Vásquez-del-Mercado E, Arenas R, Padilla-Desgarenes C. Sporotrichosis. Clin Dermatol. 2012;30(4):437–43.PubMedCrossRef Vásquez-del-Mercado E, Arenas R, Padilla-Desgarenes C. Sporotrichosis. Clin Dermatol. 2012;30(4):437–43.PubMedCrossRef
52.•
Zurück zum Zitat Macedo PM, Lopes-Bezerra LM, Bernardes-Engemann AR, Orofino-Costa R. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients. J Eur Acad Dermatol Venereol. 2015;29(4):719–24. This paper clearly describes the protocol for using potassium iodide.PubMedCrossRef Macedo PM, Lopes-Bezerra LM, Bernardes-Engemann AR, Orofino-Costa R. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients. J Eur Acad Dermatol Venereol. 2015;29(4):719–24. This paper clearly describes the protocol for using potassium iodide.PubMedCrossRef
53.
Zurück zum Zitat Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996;15(4):352–4.PubMedCrossRef Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J. 1996;15(4):352–4.PubMedCrossRef
54.
Zurück zum Zitat Yamada K, Zaitz C, Framil VM, Muramatu LH. Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 2011;53(2):89–93.PubMed Yamada K, Zaitz C, Framil VM, Muramatu LH. Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 2011;53(2):89–93.PubMed
55.
Zurück zum Zitat Agarwal S, Gopal K, Umesh, Kumar B. Sporotrichosis in Uttarakhand (India): a report of nine cases. Int J Dermatol. 2008;47(4):367–71.PubMedCrossRef Agarwal S, Gopal K, Umesh, Kumar B. Sporotrichosis in Uttarakhand (India): a report of nine cases. Int J Dermatol. 2008;47(4):367–71.PubMedCrossRef
56.
Zurück zum Zitat Ishida K, de Castro RA, Borba Dos Santos LP, Quintella LP, Lopes-Bezerra LM, Rozental S. Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis. Med Mycol. 2015;53(1):34–41.PubMedCrossRef Ishida K, de Castro RA, Borba Dos Santos LP, Quintella LP, Lopes-Bezerra LM, Rozental S. Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis. Med Mycol. 2015;53(1):34–41.PubMedCrossRef
57.
Zurück zum Zitat Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49 Suppl 1:7–10.PubMedCrossRef Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49 Suppl 1:7–10.PubMedCrossRef
58.
Zurück zum Zitat Mario DN, Guarro J, Santurio JM, Alves SH, Capilla J. In vitro and in vivo efficacy of Amphotericin B combined with posaconazole against experimental disseminated Sporotrichosis. Antimicrob Agents Chemother. 2015;59(8):5018–21.PubMedPubMedCentralCrossRef Mario DN, Guarro J, Santurio JM, Alves SH, Capilla J. In vitro and in vivo efficacy of Amphotericin B combined with posaconazole against experimental disseminated Sporotrichosis. Antimicrob Agents Chemother. 2015;59(8):5018–21.PubMedPubMedCentralCrossRef
59.•
Zurück zum Zitat Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(10):1255–65. This paper shows a practice guideline for treating sporotrichosis.PubMedCrossRef Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(10):1255–65. This paper shows a practice guideline for treating sporotrichosis.PubMedCrossRef
60.
Zurück zum Zitat de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole—study of 645 patients. Clin Infect Dis. 2011;52(12):e200–6.PubMedCrossRef de Lima Barros MB, Schubach AO, de Vasconcellos Carvalhaes de Oliveira R, Martins EB, Teixeira JL, Wanke B. Treatment of cutaneous sporotrichosis with itraconazole—study of 645 patients. Clin Infect Dis. 2011;52(12):e200–6.PubMedCrossRef
61.
Zurück zum Zitat Fernández-Silva F, Capilla J, Mayayo E, Guarro J. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis. Mycoses. 2014;57(2):121–4.PubMedCrossRef Fernández-Silva F, Capilla J, Mayayo E, Guarro J. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis. Mycoses. 2014;57(2):121–4.PubMedCrossRef
62.
Zurück zum Zitat Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Monzón A, Rodriguez-Tudela JL, Cuenca-Estrella M. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test. Mycoses. 2010;53(3):227–31.PubMedCrossRef Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Monzón A, Rodriguez-Tudela JL, Cuenca-Estrella M. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test. Mycoses. 2010;53(3):227–31.PubMedCrossRef
63.
Zurück zum Zitat Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, et al. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol. 2015;53(2):178–88.PubMedCrossRef Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, et al. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol. 2015;53(2):178–88.PubMedCrossRef
64.
Zurück zum Zitat Francesconi G, Francesconi do Valle AC, Passos SL, de Lima Barros MB, de Almeida Paes R, Curi AL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011;171(5):349–54.PubMedCrossRef Francesconi G, Francesconi do Valle AC, Passos SL, de Lima Barros MB, de Almeida Paes R, Curi AL, et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia. 2011;171(5):349–54.PubMedCrossRef
65.
Zurück zum Zitat Bargman H. Successful treatment of cutaneous sporotrichosis with liquid nitrogen: report of three cases. Mycoses. 1995;38(7–8):285–7.PubMedCrossRef Bargman H. Successful treatment of cutaneous sporotrichosis with liquid nitrogen: report of three cases. Mycoses. 1995;38(7–8):285–7.PubMedCrossRef
66.
Zurück zum Zitat Lloret A, Hartmann K, Pennisi MG, Ferrer L, Addie D, Belák S, et al. Sporotrichosis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:619–23.PubMedCrossRef Lloret A, Hartmann K, Pennisi MG, Ferrer L, Addie D, Belák S, et al. Sporotrichosis in cats: ABCD guidelines on prevention and management. J Feline Med Surg. 2013;15:619–23.PubMedCrossRef
Metadaten
Titel
Sporotrichosis in Children: an Update
verfasst von
Andrés Tirado-Sánchez
Alexandro Bonifaz
Publikationsdatum
30.05.2016
Verlag
Springer US
Erschienen in
Current Fungal Infection Reports / Ausgabe 3/2016
Print ISSN: 1936-3761
Elektronische ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-016-0259-0

Weitere Artikel der Ausgabe 3/2016

Current Fungal Infection Reports 3/2016 Zur Ausgabe

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Review on Tinea Incognita

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Pityriasis Versicolor: Clinical Spectrum and Diagnosis

Advances in Diagnosis of Invasive Fungal Infections (S Chen, Section Editor)

Diagnosis of Midwestern Endemic Mycoses

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Clinical Focus on Malassezia Folliculitis

Advances in Diagnosis of Invasive Fungal Infections (S Chen, Section Editor)

Azole Resistance in Moulds—Approach to Detection in a Clinical Laboratory

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Primary and Disseminated Cutaneous Coccidioidomycosis: Clinical Aspects and Diagnosis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.